157
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers

, , , , &
Pages 771-782 | Published online: 14 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (12)

S.P. Pandey, P. Jangied, T. Shukla, Tripathi A.N. Upmanyu. 2023. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective 280 320 .
Ignacio Rivero Berti, Tanya Singh, Tugce Boztepe, Ignacio E. Leon, Ashok KUMAR Nadda & Guillermo R. Castro. 2022. Concepts and Design of Materials Nanoarchitectonics. Concepts and Design of Materials Nanoarchitectonics 381 416 .
Hareth Y. Shujaa Edin, Nagi A. AL-Haj, Abdullah Rasedee, Noorjahan Banu Alitheen, Arifah Abdul Kadir, Chee Wun How, Heshu Sulaiman Rahman & Hussah Abdullah AL-Shwyeh. (2021) Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells. Saudi Journal of Biological Sciences 28:9, pages 5214-5220.
Crossref
Ali Sartaj, Sanjula Baboota & Javed Ali. (2021) Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast cancer. Journal of Drug Delivery Science and Technology 63, pages 102451.
Crossref
Samira Mohebbi, Monire Shariatipour, Behnaz Shafie & Mostafa M. Amini. (2021) Encapsulation of tamoxifen citrate in functionalized mesoporous silica and investigation of its release. Journal of Drug Delivery Science and Technology 62, pages 102406.
Crossref
Ritu Karwasra, Surender Singh, Khalid Raza, Nitin Sharma & Saurabh Varma. (2021) A brief overview on current status of nanomedicines for treatment of pancytopenia: Focusing on chemotherapeutic regime. Journal of Drug Delivery Science and Technology 61, pages 102159.
Crossref
Chanh Trung Nguyen, Chung Reen Kim, Thi Huong Le, Kyo-in Koo & Chang Ho Hwang. (2020) Magnetically guided targeted delivery of erythropoietin using magnetic nanoparticles. Medicine 99:19, pages e19972.
Crossref
Guan-Young Teo, Abdullah Rasedee, Nagi. A. AL-Haj, Chaw Yee Beh, Chee Wun How, Heshu Sulaiman Rahman, Noorjahan Banu Alitheen, Rozita Rosli, Al-Shwyeh Hussah Abdullah & Abdelwahid Saeed Ali. (2020) Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells. Saudi Journal of Biological Sciences 27:2, pages 653-658.
Crossref
Xueni Wang, Yuting Yang, Yating An & Gang Fang. (2019) The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer. Biomedicine & Pharmacotherapy 117, pages 109086.
Crossref
Chaw Yee Beh, Abdullah Rasedee, Gayathri Thevi Selvarajah, Latifah Saiful Yazan, Abdul Rahman Omar, Jia Ning Foong, Chee Wun How & Jhi Biau Foo. (2019) Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system. PLOS ONE 14:7, pages e0219285.
Crossref
Yaocun Yue, Dandan Zhao & Qiuwen Yin. (2018) Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Biomedicine & Pharmacotherapy 98, pages 813-820.
Crossref
Nicole Remaliah S Sibuyi, Ntevheleni Thovhogi, Kwazikwakhe B Gabuza, Miche D Meyer, Mustafa Drah, Martin O Onani, Amanda Skepu, Abram M Madiehe & Mervin Meyer. (2017) Peptide-functionalized nanoparticles for the selective induction of apoptosis in target cells. Nanomedicine 12:14, pages 1631-1645.
Crossref